Company: PBH
Filing Date: 2025-05-09
Form Type: 10-K
Source: 0001295947-25-000017
Chunk: 107

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-05-09
Form: 10-K
Item: Item 8
Chunk 107
---
 – March 31, 2024   Goodwill711,452 30,384 741,836 Accumulated impairment losses(212,516)(1,587)(214,103)Balance - March 31, 2024$498,936 $28,797 $527,733 Adjustment related to acquisition (a)— 309 309 Effects of foreign currency exchange rates— (617)(617)Balance – March 31, 2025   Goodwill711,452 30,076 741,528 Accumulated impairment losses(212,516)(1,587)(214,103)Balance - March 31, 2025$498,936 $28,489 $527,425 (a) On January 8, 2024, our Australian subsidiary acquired one of its suppliers.  In connection with this acquisition, we preliminarily allocated $0.6 million to goodwill in fiscal 2024 and made an adjustment of $0.3 million to the preliminary amount in fiscal 2025.  At February 28, 2023, in conjunction with the annual test for goodwill impairment, which coincided with our annual strategic planning process, we recorded an impairment charge of $48.8 million to adjust the carrying amount of goodwill related to our North American Women's Health and North American Oral Care reporting units.  The impairment charges were primarily a result of increased discount rates due to macroeconomic conditions.At February 29, 2024 and February 28, 2025, in conjunction with the annual tests for goodwill impairment, which coincided with our annual strategic planning process, the estimated fair value exceeded the carrying value for all reporting units and accordingly, no impairment charge was taken in either period.We identify our reporting units in accordance with the FASB ASC Subtopic 280.  The carrying value and fair value for intangible assets and goodwill for a reporting unit are calculated based on key assumptions and valuation methodologies.  The discounted cash flow methodology is a widely accepted valuation technique utilized by market participants in the transaction evaluation process and has been applied consistently.  We also considered our market capitalization at February 28, 2025 and February 29, 2024, as compared to the aggregate fair values of our reporting units, to assess the reasonableness of our estimates pursuant to the discounted cash flow methodology.  The estimates and assumptions made in assessing the fair value of our reporting units and the valuation